Brief: Agile Therapeutics Reports First Quarter 2020 Financial Results

Agile Therapeutics

05/05/2020 22:29

May 5 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL
RESULTS
    * Q1 LOSS PER SHARE $0.10
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.09 -- REFINITIV IBES
DATA
    * 93.9 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31,
2020
    * EXPECTS OPERATING EXPENSES FOR FULL YEAR 2020 TO BE IN
RANGE OF
$52.0 MILLION TO $56.0 MILLION
    * NET REVENUE IN Q4 OF 2020, REFLECTING INITIAL LAUNCH OF
TWIRLA,
IS EXPECTED TO BE IN RANGE OF $4.0 MILLION TO $6.0 MILLION

Source text for Eikon:  ID:nGNX4CjM30 
Further company coverage:  AGRX.O 

 ((Briefs@thomsonreuters.com;))